At the J.P. Morgan Healthcare Conference in January—back when few could predict the looming destruction of COVID-19—Amgen CEO […]
Author: Clinical Editor
Gilead Sciences scored a massive win earlier this week with its first positive data readout for investigational candidate […]
AbbVie may be working through COVID-19, but it’s pressing ahead with its Allergan merger, too—and taking stock of products […]
NHS England has set out details of which regular services should be prioritised for resumption over the next […]
Antiviral drug remdesivir helps patients hospitalised with covid-19 recover faster and may also reduce mortality, according to the […]
A research programme to determine the prevalence of covid-19 in the community and the proportion of the population […]
The recommendations bring closer to approval new therapies for asthma, acute myeloid leukaemia, transfusion-dependent anaemia, diabetes, prostate cancer, […]
It is expected that the move will allow the EMA to complete its assessment of the drug significantly […]
NICE is sharing its work with initiatives such as the WHO’s Evidence Collaborative for COVID-19
ATTRACT (Angiotensin II Type Two Receptor Agonist Covid-19 Trial) is targeting hospitalised patients treated with basic respiratory care, […]